Bill Ackman Pershing Square Capital Management
Bill Ackman is the founder and CEO of Pershing Square Capital Management, a New York–based hedge fund. He employs an activist investing approach, seeking to influence the management and direction of the publicly traded companies in which he invests. Frequently in the public eye, Ackman has been noted for both high-profile successes and controversies, such as his well-known short position in Herbalife.
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$976M |
| 2 |
Canadian Pacific Kansas City
CP
|
+$553M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 21.68% |
| 2 | Materials | 19.42% |
| 3 | Healthcare | 19.16% |
| 4 | Consumer Staples | 17.44% |
| 5 | Industrials | 16.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Restaurant Brands International
QSR
$25.9B
| $1.63B | 21.68% |
39,150,551
| – | – |
2014 Q4
6 quarters
|
|
|
2
Canadian Pacific Kansas City
CP
$77.4B
| $1.27B | 16.87% |
49,204,450
-20,500,000
| -29% | -$553M |
2013 Q2
12 quarters
|
|
3
Air Products & Chemicals
APD
$67.4B
| $1.08B | 14.37% |
8,216,832
| – | – |
2013 Q2
12 quarters
|
|
4
Mondelez International
MDLZ
$80.1B
| $1.04B | 13.9% |
22,942,225
| – | – |
2015 Q3
3 quarters
|
|
|
5
Zoetis
ZTS
$32.9B
| $1B | 13.38% |
21,173,188
-20,649,957
| -49% | -$976M |
2014 Q3
7 quarters
|
|
6
Bausch Health
BHC
$2.41B
| $435M | 5.79% |
21,591,122
| – | – |
2015 Q1
5 quarters
|
|
7
Howard Hughes
HHH
$4.1B
| $408M | 5.43% |
3,742,850
| – | – |
2013 Q2
12 quarters
|
|
8
Element Solutions
ESI
$8.86B
| $380M | 5.05% |
42,737,394
| – | – |
2014 Q1
9 quarters
|
|
9
Nomad Foods
NOMD
$1.65B
| $266M | 3.54% |
33,333,334
| – | – |
2016 Q1
1 quarter
|
|
Similar funds
Bill Ackman's Q2 2016 Portfolio in Review
As of Q2 2016, Bill Ackman held 9 positions worth $7.51B, down 15% from $8.85B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Bill Ackman withdrew a net $1.53B in Q2 2016, reducing 2 holdings. Its largest reduction was Zoetis, cutting an estimated $976M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, up from 17% a quarter earlier, followed by Materials and Healthcare.
- Bill Ackman's biggest Q2 2016 reduction was Zoetis, cutting an estimated $976M.
- Bill Ackman's ten largest holdings make up 100% of its $7.51B portfolio in Q2 2016.
- Bill Ackman opened 0 new positions and closed 0 in Q2 2016.
- Bill Ackman's portfolio value fell 15% quarter-over-quarter to $7.51B.
Based on Pershing Square Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.